ENTITY

KYAN Therapeutics (2198779D US)

Analysis

Health Care • Singapore

KYAN Therapeutics, Inc. is a biotechnology company. The Company tackles the complexity of cancer by combining small data AI and biological experiments. KYAN Therapeutics serves customers in the United States.

Refresh

No filings found

We’ll display filings we find for KYAN Therapeutics here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00